Dergiler / Turkish journal of physical medicine and rehabilitation / 2019 / Cilt: 65 - Sayı: 2

The prevalence of comorbidity and predictors in ankylosing spondylitis

Sayfa
132–138
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Age, disease duration, and BASFI scores were found to be predictors ofcomorbidities in our patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of the present study was to investigate the prevalence of comorbidities and related factors in patients with ankylosingspondylitis (AS).Patients and methods: Between June 2013 and January 2014, a total of 100 patients with AS (64 males, 36 females; mean age 43.1±10.7 years;range, 25 to 73 years) who were under routine follow-up in the outpatient clinic were included in this cross-sectional study.
📊
Temel Bulgular & Veri:Both the numberand severity of the affected systems were scored.Results: The mean amount of cigarette consumption was 17.3±13.5 pack/year.
💡
Sonuç & Katkı:Age, disease duration, and BASFI scores were found to be predictors ofcomorbidities in our patients.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of the present study was to investigate the prevalence of comorbidities and related factors in patients with ankylosingspondylitis (AS).Patients and methods: Between June 2013 and January 2014, a total of 100 patients with AS (64 males, 36 females; mean age 43.1±10.7 years;range, 25 to 73 years) who were under routine follow-up in the outpatient clinic were included in this cross-sectional study. The demographiccharacteristics of the patients were recorded. The Ankylosing Spondylitis Disease Activity Scale (ASDAS), Bath Ankylosing SpondylitisDisease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath Ankylosing Spondylitis Metrology Index(BASMI) scores were calculated. Comorbidities were evaluated using the modified Cumulative Illness Rating Scale (CIRS). Both the numberand severity of the affected systems were scored.Results: The mean amount of cigarette consumption was 17.3±13.5 pack/year. The mean disease duration was 191.3±122.4 months. TheBASFI, BASDAI, BASMI, and ASDAS-C-reactive protein scores were 3.4±2.3, 3.7±2.0, 4.5±1.8, and 2.5±0.9, respectively. The mean number ofsystem-related problems was 4.3 (range, 1 to 11). The mean CIRS scores for the severity of comorbidities were 7.36±3.48 (range, 3 to 23). Themost frequent system combinations were hematopoietic, eye, ear, nose and throat, and upper gastrointestinal in 11 patients, hematopoietic,respiratory and upper gastrointestinal in 11 patients, and hematopoietic, respiratory and eye, ear, nose and throat in 10 patients. When theestimated total CIRS scores was assessed in the multivariate reduced model, age, disease duration, and BASFI values showed a significantindependent effect.Conclusion: Our study results showed that the frequency of comorbidities was more than four, although the severity of system problemswere mild in AS patients as measured by CIRS. The most frequently involved systems included hematopoietic, upper gastrointestinal,lower gastrointestinal, renal, and musculoskeletal-skin systems. Age, disease duration, and BASFI scores were found to be predictors ofcomorbidities in our patients.

🔖

Bu Makaleye Atıf Yap

GÖKŞENOĞLU, G., BUĞDAYCI, D., PAKER, N., YILDIRIM, M. A., ETLİ, Ö. (2019). The prevalence of comorbidity and predictors in ankylosing spondylitis. Turkish journal of physical medicine and rehabilitation, Cilt: 65 - Sayı: 2, 132–138. https://ajindex.com/articles/375164

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Feinstein AR. The pre-therapeutıc classification of co-morbidity in chronic disease. J Chronic Dis 1970;23:455-68
  2. Fillenbaum GG, Pieper CF, Cohen HJ, Cornoni-Huntley JC, Guralnik JM. Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. J Gerontol A Biol Sci Med Sci 2000;55:84-9
  3. Ursum J, Nielen MM, Twisk JW, Peters MJ, Schellevis FG, Nurmohamed MT, et al. Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study. BMC Fam Pract 2013;14:199
  4. Mathieu S, Gossec L, Dougados M, Soubrier M. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011;63:557-63
  5. Bremander A, Petersson IF, Bergman S, Englund M. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2011;63:550-6
  6. Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis 2010;69:1165-8
  7. Rijken M, van Kerkhof M, Dekker J, Schellevis FG. Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning. Qual Life Res 2005;14:45-55
  8. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622-6
  9. Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med 2012;10:134-41
  10. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41:237-48
  11. Hudon C, Fortin M, Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol 2005;58:603-8
  12. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Medm2005;3:223-8
  13. Em S, Bozkurt M, Çağlayan M, Oktayoğlu P, Karakoç M, Nas N. The evaluation of comorbid diseases in patients with ankylosing spondylitis. Dicle Med J 2014;41:662-6
  14. Garip Y, Eser F, Dortbas F, Kılıcarslan A, Bodur H. Comorbidity profiles among patients with ankylosing spondylitis. Marmara Medical Journal 2016;29:23-8
  15. Braun J, van der Heij